
今年1至8月戒菸服務已達37.3萬人次,國健署副署長魏璽倫表示未來將依不同年齡層需求提供相應服務。
衛福部國健署副署長魏璽倫指出,我國成人吸菸率降至12.8%,戒菸服務量逐年攀升,今年1至8月已服務37.3萬人次。國健署未來擬推出依年齡層與動機差異的「精準戒菸」模式。
AI-generated summary
台灣成人吸菸率從2022年的14%降至2024年的12.8%,慢性阻塞性肺病(COPD)每年奪走國內超過5千人性命。
魏璽倫說,不同年齡層的吸菸動機、面臨的生活問題等存在差異,未來希望推出「精準戒菸」模式。(記者林志怡攝)
〔記者林志怡/台北報導〕近年來民眾健康意識提升,也更清楚吸菸對健康的危害。衛福部國民健康署副署長魏璽倫說,近年來我國吸菸率持續下降,吸菸者戒菸服務使用量則逐年攀升,服務對象涵蓋傳統紙菸、加熱菸、電子煙等,今年1至8月已服務37.3萬人次,未來也希望依據戒菸者需求,推出「精準戒菸」模式。
慢性阻塞性肺病(COPD)是一種呼吸道長期發炎導致無法恢復的呼吸道阻塞,全球每10秒鐘就有一個人死於COPD,台灣一年更有超過5千人因COPD死亡,而吸菸者發生COPD的風險高出非吸菸者6.3倍,因此戒菸是預防COPD的第一步。
魏璽倫指出,我國多年推動菸害防制與戒菸服務,國內成人吸菸率已從2022年的14%降至2024年的12.8%;且戒菸服務量逐年攀升,2025年達到46.5萬人次,較2023年成長約20%,今年也維持成長趨勢,今(2026)年1至8月已服務37.3萬人次,比去年同期增加13.3%。
國健署統計,接受戒菸服務民眾6個月戒菸成功率平均約30%。魏璽倫表示,我國戒菸成功率與國際數據相近且表現較佳,今年起因應加熱菸、電子煙等新興菸品出現,將此類菸品使用者納入戒菸服務對象,其中加熱菸所需的用藥可比照傳統紙菸,電子煙使用者則提供戒菸衛教服務。
魏璽倫也提到,考量不同年齡層的吸菸動機、面臨的生活問題等存在差異,比如青少年吸食加熱菸、電子煙可能是因為同儕,成人則可能是因為工作壓力大,不應該預設所有走進診間的戒菸者樣態都完全一樣,未來希望提供「精準戒菸」模式,依據需求提供相應的戒菸服務,但細節還在討論中。
此外,魏璽倫指出,目前全台有近3000家醫院、診所、衛生所及藥局提供戒菸服務,並已提供住院病患戒菸補助,國健署也希望與醫策會合作,將戒菸服務納入臨床照顧品質計劃的KPI中,呼籲吸菸者多加利用戒菸服務,及早脫離菸癮,遠離肺阻塞。
AI outlook — possibilities, not facts
國健署未來將推出「精準戒菸」模式
Within months

Recently, a nutritious lunch at Seongyeon High School was insufficient. A student purchased sizzling noodles from the deli department and found that the noodles were stained light green. Councilor Chen Yijun criticized Mayor Jiang Wanan's inspection for "treating the symptoms rather than the root cause." The school explained that the green marks were caused by the penetration of marker pen ink, and the manufacturer was penalized and fined NT$10,000.

In 2026, a Chinese expert consensus was released, recommending moderate-intensity statins combined with ezetimibe as the initial cholesterol-lowering strategy for extremely high-risk groups. With the inclusion of ezetimibe in the National Essential Medicines List, the accessibility of blood lipid management and combination medication for grassroots patients will be significantly improved.

Hong Kong is expanding clinical trials of histotripsy, a non-invasive focused ultrasound treatment for tumors, targeting kidney cancer across three local medical centers.

A team from the University of Cambridge in the United Kingdom and the University of Oregon Health and Science in the United States published a study in Science and pointed out that cancer cells release PRDX1 protein to consume reactive oxygen species, causing immune T cells to lose the signal to initiate an attack. This discovery is expected to provide new directions for cancer immunotherapy, and related research is currently in the preclinical stage.

Jianqiao Xinyuan and Nippon Jusen Pharmaceutical jointly announced that the oral GnRH antagonist "Astin® Film-Coated Tablets 100 mg" has been approved by the Ministry of Health and Welfare as a new indication for endometriosis. Taiwan has become the first approved market in Asia to provide women of childbearing age with a new oral treatment option.

A man in his 50s traveled to Japan and developed acute urinary retention after taking commercially available cold medicine. Physician Chen Yuxin pointed out that the first-generation antihistamines and pseudoephedrine in cold medicines are the two main culprits of locking urine, and reminded four high-risk groups such as those with prostate hypertrophy and middle-aged and elderly men to be more vigilant when taking medicines.